Core Viewpoint - Hongyuan Pharmaceutical (301246.SZ) has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products and holds a leading market share in the active pharmaceutical ingredient metronidazole, with products sold to dozens of countries and regions globally, establishing good partnerships with well-known pharmaceutical companies both domestically and internationally [1] Group 1 - The company has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products [1] - The company holds a leading market share in metronidazole active pharmaceutical ingredients [1] - The company's products are sold to dozens of countries and regions globally [1] Group 2 - The company has established good partnerships with well-known pharmaceutical companies [1]
宏源药业(301246.SZ)：目前公司现有六氟磷酸锂产品设计产能8000吨/年